| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |